The present disclosure is related to heterocyclyl compounds as MEK inhibitors. These compounds include heterocyclyl compounds of formula (I) and (Ia), their pharmaceutically acceptable salts, their combinations with suitable medicaments, and pharmaceutical compositions thereof. The present disclosure also includes processes of preparation of the compounds and their use in methods of treatment. The compounds as disclosed herein are of Formula (I) below:
本公开涉及
杂环化合物作为MEK
抑制剂。这些化合物包括式(I)和(Ia)的
杂环化合物,它们的药学上可接受的盐,与适当药物的组合,以及其药物组合物。本公开还包括所述化合物的制备方法和它们在治疗方法中的应用。所述化合物的
化学式如下:Formula (I)